16 October 2020 01:16
According to the preliminary results of the experiment, an immune response was obtained in healthy volunteers. An antibody response arrived in all participants by the 42nd day
Antibody Response in Volunteers – The trial of the “BBIBP-CorV” vaccine was conducted in China from April 29 to July 30, 2020. The study showed an antibody response in all participants by the 42nd day after vaccination.
The protection of the elderly is fundamental – “The protection of the elderly is a key goal for an effective Covid vaccine as this group is at greater risk. It is therefore encouraging that this vaccine induces antibody responses even in the elderly over 60 and beyond,” says Xiaoming Yang, one of the study authors.
–